SCHEMBL25370694

SCHEMBL25370694

CS(=O)(=O)Nc1cccc(NC(=O)c2cc(C(=O)NCc3nc4ccccc4[nH]3)cs2)c1

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 4/20 0.49
▸ TSHR P16473 3/20 0.49
▸ MAPK10 P53779 2/20 0.49
▸ KMT2A Q03164 5/20 0.47
▸ POLB P06746 2/20 0.46
▸ RAB9A P51151 2/20 0.45
▸ NPC1 O15118 1/20 0.45
▸ MAPT P10636 1/20 0.45
▸ SLC40A1 Q9NP59 2/20 0.44
▸ MEN1 O00255 3/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ NTRK1 P04629 1/20 0.42
▸ NTRK2 Q16620 1/20 0.42
▸ ITGB3 P05106 1/20 0.41
▸ ITGAV P06756 1/20 0.41
▸ ROCK1 Q13464 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30544011 1.00 SMN1; SMN2 (0.49) SMN1; SMN2TSHRMAPK10KMT2APOLB
SCHEMBL25432217 0.86 RAB9A (0.50) SMN1; SMN2KMT2ARAB9ANPC1MAPT
SCHEMBL30543921 0.86 RAB9A (0.50) SMN1; SMN2KMT2ARAB9ANPC1MAPT
SCHEMBL30544024 0.81 CSNK2A1 (0.47) KMT2AMEN1ROCK1
SCHEMBL25432990 0.81 CSNK2A1 (0.47) KMT2AMEN1ROCK1
SCHEMBL25368280 0.78 DHX9 (0.53) SMN1; SMN2KMT2APOLBRAB9AMAPT
SCHEMBL30543946 0.78 DHX9 (0.53) SMN1; SMN2KMT2APOLBRAB9AMAPT
SCHEMBL25433357 0.78 NFATC1 (0.54) KMT2ARAB9ANPC1MAPTMEN1
SCHEMBL25368472 0.76 LMNA (0.48) SMN1; SMN2RAB9ANPC1MAPTKDM4E
SCHEMBL25367979 0.76 ALDH1A1 (0.46) TSHRMAPTROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023158795-A1 INHIBITORS OF RNA HELICASE DHX9 AND USES THEREOF ACCENT THERAPEUTICS, INC. (US) 2023-08-24 — — WO claimed
WO-2023158795-A1 INHIBITORS OF RNA HELICASE DHX9 AND USES THEREOF ACCENT THERAPEUTICS, INC. (US) 2023-08-24 — — WO disclosed
WO-2023158795-A1 INHIBITORS OF RNA HELICASE DHX9 AND USES THEREOF ACCENT THERAPEUTICS, INC. (US) 2023-08-24 — — WO disclosed
Send feedback